Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

'Mozart Effect' may increase detection rates of precancerous polyps

Physicians who listen to Mozart while performing colonoscopy may increase their detection rates of precancerous polyps, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

1 Nov 2011

Aspirin may reduce risk of bowel cancer by half: Study

According to a new study published in The Lancet, a regular dose of aspirin may not only stave off heart disease but also cut the risk of developing hereditary cancer in half.

31 Oct 2011

Cigarette smokers at risk of compromised digestive function

Cigarette smoking appears to impair pancreatic duct cell function--even for those who quit--putting all smokers at risk of compromised digestive function regardless of age, gender and alcohol intake, according to the results of a study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

31 Oct 2011

Focused training increases physician's ability to find potentially precancerous polyps

Just two extra hours of focused training significantly increased the ability of physicians to find potentially precancerous polyps, known as adenomas, in the colon, according to researchers at Mayo Clinic in Florida. These findings suggest that new methods to educate endoscopists, the physicians who examine the colon, could increase colorectal cancer detection rates and potentially reduce cancer deaths.

31 Oct 2011

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Circadian Technologies Limited announces that its 100% owned subsidiary, Vegenics Pty Ltd, has received approval for its investigational new drug application from the U.S. Food and Drug Administration to initiate clinical trials of VGX-100.

31 Oct 2011

GC-C agonists have potential to delay progression of colitis into colon cancer

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.

31 Oct 2011

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

This study examined Medicare data on beneficiaries diagnosed with colorectal cancer between 1995 and 2005 who ranged from 67 to 85 years old. The authors found, "Medicare beneficiaries with colon cancer had better outcomes if they had more primary care utilization before diagnosis. Even within this universally insured population, 28% of Medicare beneficiaries with colon cancer had no or only 1 contact with primary care physicians in the 3 to 27 months before the diagnosis.

29 Oct 2011

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.

28 Oct 2011

Bayer's regorafenib Phase 3 trial on metastatic colorectal cancer meets primary endpoint

Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.

27 Oct 2011

NSAID may lower risk of death from colorectal cancer among postmenopausal women

Postmenopausal women who reported having used nonsteroidal anti-inflammatory drugs for at least 10 years at the time of enrollment in the Women's Health Initiative study had a lower risk for death from colorectal cancer compared with women who reported no use of these drugs at enrollment, according to data presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.

24 Oct 2011

Fecal immunochemical testing an inexpensive alternative to colonoscopy

Eventually, colon cancers bleed and so tests for blood in stool seem an inexpensive and noninvasive alternative to traditional colonoscopies. In fact, a recent article in the journal Cancer Prevention Research showed that fecal immunochemical testing (FIT) is an accurate predictor of colorectal cancer and can provide a low-cost screening alternative for medically underserved populations.

21 Oct 2011

Colon cancer may be linked to a bacterium that causes appendicitis and gum disease: Study

A new study shows that a bacterium that causes appendicitis and gum disease is also found in colon tumors. Researchers suggest that it may set the stage for colorectal cancer, the second-deadliest malignancy. The bacterium – fusobacterium might play a role in determining the prognosis of colorectal cancers and shaping their treatment, according to two research teams independently reporting a relationship between the rod-shaped microbe and cancers of the lower digestive system.

18 Oct 2011

Scientists discover high levels of Fusobacterium in colorectal cancers

Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.

18 Oct 2011

Cancer activist joins CNN medical correspondent for colon cancer research benefit event

Legendary journalist, best-selling author and cancer activist Katie Couric joins CNN's Sanjay Gupta, M.D. Nov. 1 for the fifth annual A Conversation With a Living Legend® luncheon benefiting The University of Texas MD Anderson Cancer Center.

15 Oct 2011

Research roundup: Racial disparities in colon cancer survival; Options to cut health spending; Covering teenagers

Survival Disparities In African American And White Colo-Rectal Cancer Patients -- Researchers analyzed results from 12 controlled clinical trials to understand disparities between black and white survivors of colorectal cancer.

14 Oct 2011

JCO publishes Keryx's KRX-0401 Phase 1 / 2 combination study on advanced MM

Keryx Biopharmaceuticals, Inc. today announced that a manuscript entitled "Perifosine Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezomib: Results of a Multicenter Phase l/2 Trial" reporting Phase 1 / 2 combination activity of KRX-0401 (perifosine) in the treatment of advanced multiple myeloma (MM) patients, was selected for publication in the October 11, 2011 online edition of the Journal of Clinical Oncology.

14 Oct 2011

SFDA approves China Medical Technologies' colorectal cancer assay

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that China's State Food and Drug Administration has approved the Company's real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog assay as a companion diagnostic test for the use of a targeted drug for the treatment of colorectal cancer patients.

13 Oct 2011

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

A new study from Spain finds that narrow band imaging appears to be a less time-consuming and equally effective alternative to chromoendoscopy for the detection of dysplasia (abnormal growths) in patients with long-standing inflammatory bowel disease.

13 Oct 2011

EMA recommends 4SC's resminostat for orphan medicinal product designation to treat HL

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the European Medicines Agency (EMA) has recommended 4SC's anti-cancer compound resminostat for designation as orphan medicinal product for the treatment of Hodgkin's Lymphoma (HL), a cancer of the lymphatic system.

13 Oct 2011

Receptor tyrosine kinases control PI3K signaling in human KRAS mutant colorectal cancers

Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene. A team of researchers led by Jeffrey Engelman, at Massachusetts General Hospital Cancer Center, Boston, has now identified a potential way to effectively use receptor tyrosine kinases inhibitors to treat individuals with KRAS mutant colorectal cancers - combine them with inhibitors of the MEK/ERK signaling pathway.

11 Oct 2011

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

'Mozart Effect' may increase detection rates of precancerous polyps

Aspirin may reduce risk of bowel cancer by half: Study

Cigarette smokers at risk of compromised digestive function

Focused training increases physician's ability to find potentially precancerous polyps

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

GC-C agonists have potential to delay progression of colitis into colon cancer

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Bayer's regorafenib Phase 3 trial on metastatic colorectal cancer meets primary endpoint

NSAID may lower risk of death from colorectal cancer among postmenopausal women

Fecal immunochemical testing an inexpensive alternative to colonoscopy

Colon cancer may be linked to a bacterium that causes appendicitis and gum disease: Study

Scientists discover high levels of Fusobacterium in colorectal cancers

Cancer activist joins CNN medical correspondent for colon cancer research benefit event

Research roundup: Racial disparities in colon cancer survival; Options to cut health spending; Covering teenagers

JCO publishes Keryx's KRX-0401 Phase 1 / 2 combination study on advanced MM

SFDA approves China Medical Technologies' colorectal cancer assay

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

EMA recommends 4SC's resminostat for orphan medicinal product designation to treat HL

Receptor tyrosine kinases control PI3K signaling in human KRAS mutant colorectal cancers

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in